CURA — Curaleaf Holdings Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Annual cashflow statement for Curaleaf Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	C2021 December 31st	C2022 December 31st	2023 December 31st	C2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-215	-265	-239	-212	-202
Depreciation
Deferred Taxes
Non-Cash Items	89.2	95.2	100	92.8	56.7
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-55.8	66	32	105	120
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Net Change in Other Assets & Liabilities
Cash from Operating Activities	-58.3	46.4	75.3	164	138
Capital Expenditures	-172	-135	-70.3	-97.4	-64.6
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	7.98	-85.2	-8.38	3.61	-5.7
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-164	-220	-78.7	-93.8	-70.3
Financing Cash Flow Items	36.2	-13.8	-15.7	-11.8	-39.6
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	449	41.8	-67	-54.2	-73.5
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	226	-136	-71.4	15.4	-5.65